European Pharmaceutical Review

OCTOBER 30, 2023

Echoes of the global health challenges we faced during the COVID-19 pandemic still linger as new variants emerge and COVID continues to make headlines. A question that continues to sit in the back of many people’s minds is what happens if there is another outbreak or global pandemic? Are we preparing and how ready are we for the next one? Vaccitech’s Chief Business Officer, Graham Griffiths, discusses key learnings in drug and vaccine development , the challenges of preparing for the unknown, an

Vaccines 114

Vaccines Drug Development 114

STAT

OCTOBER 31, 2023

Nearly six weeks after his surgery, the world’s second recipient of a genetically modified pig heart has died, the University of Maryland announced Tuesday. Lawrence Faucette, a 58-year-old resident of Frederick, Md., with terminal heart disease, died Monday. He had received the experimental xenotransplant on September 20 at the University of Maryland Medical Center in an eight-hour operation.

363

363

PharmaVoice

NOVEMBER 2, 2023

From Merck and J&J to AbbVie and Eisai, the oncology field has stayed consistently devoted to churning out important therapies.

265

265

ALiEM - Pharm Pearls

NOVEMBER 3, 2023

Welcome to the AIR Trauma Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Digital Impact Factor [1], the ALiEM AIR Team is proud to present the highest quality online content related to related to trauma in the Emergency Department. 8 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board.

Labelling 211

Labelling 211

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

BioPharma Dive

OCTOBER 31, 2023

The high-profile meeting focused on the theoretical risks of CRISPR gene editing, as both the FDA and its advisory committee appeared convinced by the efficacy of the companies’ exa-cel treatment.

133

133

STAT

NOVEMBER 3, 2023

More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker. The tracker has collected data on Medicaid enrollment since the first states began redetermining eligibility in April, after the expiration of the federal requirement of continuous coverage during the Covid-19 public health emergency.

361

361

Pharmafile

NOVEMBER 1, 2023

AstraZeneca has announced a collaboration and investment agreement with Cellectis for the development of next generation cell and gene therapeutics (CGTs) in areas such as oncology, immunology and rare diseases. Under terms of this agreement, AstraZeneca will utilise Cellectis’ proprietary gene editing technologies and manufacturing capabilities with the intention of designing novel CGT products. 25 […] The post AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine

116

116

BioPharma Dive

OCTOBER 31, 2023

Expert advisers are reviewing the companies’ case for approval of what could be the first medicine based on the gene editing technology. Follow their discussion here.

131

131

STAT

OCTOBER 31, 2023

Editor’s note: This essay contains spoilers for the Netflix show “The Fall of the House of Usher.” “W atch “ The Fall of the House of Usher” on Netflix when you can. F**cking Great! Totally based on the Sacklers—Fictional obviously but so damn good!

361

361

PharmaVoice

NOVEMBER 1, 2023

From hallucinations to data privacy, pharma looks to iron out the kinks of generative AI.

289

289

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

European Pharmaceutical Review

NOVEMBER 2, 2023

While unsolicited and burdensome, medicine shortages are an obstacle faced by the pharmaceutical industry. In 2023, a combination of factors, including increased demand (particularly for critical medicines), economic inflation, as well as international geopolitical unrest, has led to Europe’s supply chain being acutely affected. Consequently, regulators, trade groups and other organisations have worked to prevent and alleviate medicine shortages in the region.

115

115

BioPharma Dive

NOVEMBER 3, 2023

The company recorded a net loss in the third quarter as it “resizes” its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance.

Vaccines 122

Vaccines 122

STAT

NOVEMBER 2, 2023

A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine , a common medication used to treat opioid addiction, via telehealth. The measure, known as the Telehealth Response for E-prescribing Addiction Therapy Services Act — TREATS, for short — would permanently extend a temporary, Covid-era policy that allowed patients to receive buprenorphine remotely, without an in-person visit.

354

354

PharmaVoice

OCTOBER 31, 2023

Roivant CEO Matt Gline and Telavant CEO Frank Torti know Roivant’s position as buyers and sellers in the pharma industry, and they’re embracing those opportunities.

174

174

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

NOVEMBER 1, 2023

In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. 1 WHO’s analysis was stark. It asserted the need to accelerate trials for AMR-related vaccines in late‑stage development and maximise the use of those already on the market.

Vaccines 115

Vaccines Immunity Immunization Drug Development 115

Pharma Times

NOVEMBER 3, 2023

Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented - News - PharmaTimes

147

147

STAT

NOVEMBER 2, 2023

Our minds have a weird and wondrous way of transporting us to other places and times. You might find yourself, for instance, immersed in the vivid world of a novel, or reminiscing about a potluck with close friends. These reveries can feel magical, but they’re the result of complex electric signals zipping through the brain. Now a new study shows we’re not the only ones with an imagination.

351

351

PharmaVoice

NOVEMBER 2, 2023

A challenging funding environment and lack of partnering deals have contributed to the market's ongoing troubles.

174

174

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

OCTOBER 30, 2023

A large-scale study led by researchers at the University of Cincinnati and New York’s largest health care provider, Northwell Health, suggests that metformin can help prevent or reduce weight gain in youth taking second-generation antipsychotics (SGAs) to treat bipolar disorder. SGAs used to treat bipolar disorder are often effective at helping young patients’ mental health improve but can have significant side effects including elevated blood pressure and glucose, increased appetite, as w

Diabetes 111

Diabetes 111

Pharma Times

OCTOBER 31, 2023

Around 400,000 eligible patients are set to benefit from the travel offer - News - PharmaTimes

146

146

STAT

NOVEMBER 1, 2023

Most lung cancer screening guidelines hinge on how much people smoked tobacco and when they last smoked, but the American Cancer Society now says it doesn’t matter how long ago they quit. On Wednesday, the ACS released guidance recommending that anyone with a significant smoking history get an annual low-dose CT scan for lung cancer. The new guidelines also expand the age range for lung cancer screening to 50 through 80, instead of 55 through 74, and lower the smoking history requirement

360

360

The Pharmacist

OCTOBER 30, 2023

The General Pharmaceutical Council (GPhC) has extended the revalidation deadline, giving pharmacists due to submit their revalidation by 31 October an extra week to do so, following technical issues with its website. Pharmacists that were due to revalidate by the end of October now have until 11:59pm on Tuesday 7 November 2023 to submit their […] The post Revalidation deadline extended after GPhC technical issues appeared first on The Pharmacist.

112

112

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

OCTOBER 30, 2023

Suven Life Sciences announced positive topline results from its Phase-2 proof-of-concept study assessing the safety and efficacy of Samelisant for the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy. The study met primary endpoint, with Samelisant demonstrating statistically significant and clinically meaningful reduction in EDS measured by the ESS total score compared to placebo at Day 14 (p<0.05).

112

112

PharmaTech

NOVEMBER 2, 2023

Pharmaceutical Technology Europe® speaks with Joren van der Horst from Luo Automation, a Dutch company focused on automated visual inspection solutions, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

105

105

STAT

OCTOBER 29, 2023

My husband’s cancer came back this summer after not being evident for almost two years. With advances in cancer surveillance, we now speak of cancer survivors being cancer-free far less frequently. If you are among the luckiest unlucky who survive treatment for metastatic cancer and receive clear scans, you simply have “no evidence of disease.

345

345

European Pharmaceutical Review

NOVEMBER 1, 2023

The European Commission has authorised the Nuvaxovid XBB.1.5-adapted COVID-19 vaccine, developed by Novavax for this autumn and winter season. The vaccine, known as Nuvaxovid XBB.1.5, is to be used for preventing COVID-19 in adults and children from 12 years of age. It was developed to target Omicron XBB in line with recommendations from the European Medicines Agency’s Emergency task force (ETF) as well as other international regulators and the World Health Organization.

Vaccines 105

Vaccines Immunity Immunization 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Med Ed 101

OCTOBER 29, 2023

How many times have you picked up, dispensed, or seen an auxiliary label on a medication encouraging you to avoid alcohol while taking it? It’s definitely information that could come up on a board exam at some point throughout your career! Below is a table listing the top 5 alcohol and medication interactions. These 5 […] The post Top 5 Alcohol and Medication Interactions appeared first on Med Ed 101.

Labelling 105

Labelling 105

Express Pharma

NOVEMBER 1, 2023

In September this year, Alkem Laboratories sharpened focus on its API business, branding it as Alkem Activa. Promoter-MD Sandeep Singh’s ambition “to propel Alkem Activa into the forefront of the API market” no doubt echoes the sentiments of many API contract manufacturers in India. The logic is simple. API makers across the world are rebounding from COVID-related disruptions in 2020.

108

108

STAT

OCTOBER 30, 2023

When the human body is exposed to extreme heat, it tries to fight back. To keep us from cooking, our hearts pump faster and harder to distribute the hot blood out to our fingers and toes, away from precious internal organs. We produce more sweat, and when it evaporates, the blood beneath the skin’s surface cools down, helping to lower our body temperature.

363

363

European Pharmaceutical Review

OCTOBER 31, 2023

Alfasigma has signed a letter of intent to acquire Jyseleca – a JAK1 preferential inhibitor – from Galapagos for up to €170 million, plus royalties on European sales. Jyseleca ( filgotinib ) is an oral once-daily medication, currently approved for two indications: rheumatoid arthritis and ulcerative colitis. The planned transactions will see Galapagos transfer Jyseleca to Alfasigma, along with European and UK marketing authorisations and associated development activities.

Labelling 105

Labelling 105

The Pharmacist

NOVEMBER 3, 2023

Pharmacists have called for greater awareness of the profession after an MP appeared to mistakenly refer to the profession as ‘pharmacologists’ on BBC Question Time last night. Member of Parliament for Horsham and Cabinet Office minister Jeremy Quin highlighted the roles of ‘pharmacologists’ working in general practice in response to a comment made by a […] The post Pharmacists call for greater awareness following Question Time comment appeared first on The Pharmacist.

107

107